Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Brukinsa 80mg Capsule
Manufacturer/Marketed By : GLENMARK PHARMACEUTICALS LTD
$2974.92 $2688.74
Brukinsa 80mg Capsule is a prescription medicine used to treat certain types of blood cancers. It contains Zanubrutinib, which belongs to a class of drugs called BTK inhibitors. These medicines...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Active Pharmaceutical Ingredient
Brukinsa 80mg Capsule
$2,974.92
$2,688.74
Brukinsa 80mg Capsule is a prescription medicine used to treat certain types of blood cancers. It contains Zanubrutinib, which belongs to a class of drugs called BTK inhibitors. These medicines work by blocking a protein that helps cancer cells grow and survive, so they slow down or stop the spread of cancer in the body. Doctors usually prescribe Brukinsa 80mg Capsule to people who’ve already had other treatments for blood cancer. It’s taken by mouth and usually comes as a capsule. While it can be effective, it’s not suitable for everyone. People with serious liver problems, certain heart issues, or women who are pregnant or breastfeeding should not use this medicine unless a doctor says it’s safe. Before starting the treatment, your doctor will do some blood tests to make sure the medicine is right for you. They’ll also check your health regularly during the treatment to make sure everything stays on track.
Active Pharmaceutical Ingredient
Uses
• Mantle Cell Lymphoma (MCL) – in adults who’ve had at least one previous treatment
• Chronic Lymphocytic Leukaemia (CLL) or Small Lymphocytic Lymphoma (SLL)
• Waldenström’s Macroglobulinemia (WM)
• Marginal Zone Lymphoma (MZL) – after treatment with an anti-CD20 medicine
• Follicular Lymphoma (FL) – limited use or under review in some places
Benefits
Brukinsa 80mg Capsule is used in the treatment of certain types of blood cancers, including mantle cell lymphoma and other B-cell malignancies. It works by blocking specific proteins that help cancer cells grow and survive, thereby slowing down or stopping their progression. By targeting these pathways, this medicine helps control the spread of cancer and may reduce tumor burden. It also helps improve symptoms related to the disease, supporting better overall health and quality of life when taken as prescribed.
Side Effects
Common Side Effects:
Most Common Side Effects
• Serious infections (fever, chills, shortness of breath)
• Bleeding or blood in stool/urine
• Irregular heartbeat or chest pain
• Liver problems (yellowing of skin or eyes)
• Severe allergic reactions (swelling, rash, difficulty breathing)
Common Side Effects
• Diarrhea
• Muscle pain
• Cough
• Rash
• Low white blood cell count
• Tiredness
• Bruising easily
How To Use
You can take Brukinsa 80mg Capsule by mouth, usually once or twice a day, depending on your doctor’s advice. You can take it with or without food, but make sure to take it around the same time each day. Swallow the capsule whole; don’t crush or chew it.
Safety Advice
• Pregnancy: Brukinsa 80mg Capsule may cause harm to the unborn baby and is not recommended during pregnancy. Women of childbearing age should use effective birth control during treatment and for at least one week after stopping the medicine.
• Breast Feeding: It is unknown whether Brukinsa 80mg Capsule passes into breast milk. However, due to the potential risk to the infant, breastfeeding should be avoided during and for at least one week after the last dose.
• Lungs: Brukinsa 80mg Capsule may increase the risk of infections, including lung infections. Inform your doctor immediately if you develop cough, fever, or shortness of breath.
• Liver: Patients with liver disease should take Brukinsa 80mg Capsule only under strict medical supervision, as the medicine is processed by the liver. Dose adjustments may be required.
• Alcohol: Avoid drinking alcohol while taking Brukinsa 80mg Capsule, as it can increase the risk of liver problems and reduce the body’s ability to fight infections.
• Driving: Brukinsa 80mg Capsule may cause tiredness or dizziness in some people. Avoid driving or operating machinery until you know how the medicine affects you.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.